Delivery Order SPE2DB22D1202-SPE2DB25FVHP8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Nexletol 180 mg tablets (30-unit packaging) valued at $1,389.23. This competitively awarded, firm fixed-price delivery order is non-set-aside and has a completion date of July 31, 2025. The award is issued to AmerisourceBergen Drug Corp's Corporate Office, with performance taking place at the company's Conshohocken, Pennsylvania headquarters, which serves as a major hub for...
- The Defense Logistics Agency awarded a $1,250.17 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Nexletol 180 mg on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is the contractor's...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NEXLETOL 180 MG TABLET, a medication, with a ceiling value of $1,579.44 and a period of performance through April 30, 2025. The contract is not designated as a set-aside and is a firm-fixed price delivery order. AmerisourceBergen Drug Corp, the prime contractor, is a for-profit organization based in...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DB22D3004|SPE2DB24FPZ07) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Nexletol 180 mg tablets. The $1,017.34 award has an ultimate completion date of April 15, 2024 and does not utilize a set-aside designation. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,342.52, is for the supply of NEXLETOL 180 MG TABLET medical products. It is a firm fixed-price contract with a period of performance through November 7, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of NEXLETOL 180 MG TABLET, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $4,981.37. The ultimate completion date is September 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 180 mg Nexletol tablets, a medication used to treat high cholesterol. The contract has a ceiling value of $1,030.70 and a completion date of June 26, 2025. It is a Firm Fixed Price contract, meaning the price is set and will not change. The contract is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of NEXLETOL 180 MG TABLET in 30-count units. The contract has a ceiling value of $1,632.84 and runs through September 9, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing a wide range of...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,736.73 award is for the supply of NEXLETOL 180 MG Tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) on a Firm Fixed Price contract. The order is for 4567888111 NEXLETOL 180 MG TABLET UU 30S and has a ceiling value of $1,201.20. The ultimate completion date is April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVHP8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Nexletol 180 mg tablets in quantities of 30 units. This competitive, firm fixed-price delivery order carries a ceiling value of $1,269.01 and has an ultimate completion date of August 19, 2025. The contract involves no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support military and veteran healthcare systems. The company maintains an extensive portfolio of delivery orders through its DLA prime vendor contract, ranging from small-value transactions to substantial orders exceeding $45,000. Nexletol, prescribed primarily for cholesterol management, represents one component of the company's broad pharmaceutical supply capabilities supporting Defense Health Agency and other federal healthcare customers through the flexible DLA Troop Support Medical vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/18/25 |